Incidence of bacterial respiratory infection and pneumonia in people with HIV with and without airflow limitation

被引:1
|
作者
Heidari, Safura-Luise [1 ]
Hove-Skovsgaard, Malene [1 ]
Arentoft, Nicoline Stender [1 ]
Svartstein, Anne-Sophie W. [1 ]
Moller, Dina Leth [1 ]
Jensen, Christian Salgard [2 ]
Benfield, Thomas [3 ]
Jensen, Jens-Ulrik Stoehr [4 ,5 ]
Thudium, Rebekka Faber [1 ]
Nielsen, Susanne D. [1 ,5 ]
机构
[1] Copenhagen Univ Hosp, Rigshosp, Viro immunol Res Unit, Dept Infect Dis, Copenhagen, Denmark
[2] Copenhagen Univ Hosp, Dept Clin Microbiol, Rigshosp, Copenhagen, Denmark
[3] Copenhagen Univ Hosp Amager & Hvidovre, Ctr Res & Disrupt Infect Dis, Copenhagen, Denmark
[4] Copenhagen Univ Hosp, Herlev & Gentofte Hosp, Dept Med, Sect Resp Med, Copenhagen, Denmark
[5] Univ Copenhagen, Fac Hlth & Med Sci, Dept Clin Med, Copenhagen, Denmark
关键词
HIV; Pneumonia; Airflow limitation; Smoking; Streptococcus pneumoniae; Spirometry; COMMUNITY-ACQUIRED PNEUMONIA; HOSPITALIZATION;
D O I
10.1016/j.ijid.2023.12.009
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Objectives: We aimed to determine the incidence rate, pathogen composition, and risk factors, particularly airflow limitation, associated with bacterial respiratory infection and pneumonia in a prospective cohort of well-treated people with HIV (PWH) between 2015-2021. Methods: We included 1007 PWH from the Copenhagen Comorbidity in HIV infection (COCOMO) study. Spirometry was performed at inclusion. Microbiology samples were collected prospectively. Cumulative incidence was determined by the Aalen-Johansen estimator. Cox proportional hazard models were used to calculate risk factors, adjusted for traditional and HIV-specific variables. Results: The incidence rates of first bacterial respiratory infection and pneumonia were 12.4 (95% CI 9.7-15.5) and 5.5 (95% CI: 3.8-7.7) per 10 0 0 person-years, respectively. The cumulative incidence of pneumonia was four times higher in PWH with airflow limitation (11.8% vs 3.2%, P < 0.001). Risk factors for bacterial respiratory infection were airflow limitation (hazard ratio [HR] 2.9, [95% CI: 1.7-5.1], P < 0.001), smoking (HR 2.3, [95% CI: 1.4-3.8], P < 0.001), and previous AIDS-defining event (HR 2.0, [95% CI: 1.2-3.3], P = 0.009). For pneumonia, airflow limitation (HR 2.7, [95% CI: 1.2-6.3], P = 0.016), smoking (HR 2.5, [95% CI: 1.2-5.4], P = 0.016), and older age (HR 1.5, [95% CI: 1.1-2.1], P = 0.015) were identified as risk factors. Conclusions: Increased emphasis on airflow limitation prevention, including smoking cessation, may reduce the burden of bacterial respiratory infection and pneumonia in PWH. (c) 2024 The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases. This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ )
引用
收藏
页码:183 / 191
页数:9
相关论文
共 50 条
  • [21] Severe Respiratory Viral Infection Increases Procalcitonin in the Absence of Bacterial Pneumonia
    Gautam, S.
    Cohen, A.
    Stahl, Y.
    Toro, P. Valda
    Young, G.
    Yan, X.
    Kunitomo, Y.
    Card, M.
    Tsang, D.
    Cruz, C. S. Dela
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2020, 201
  • [22] Severe respiratory viral infection induces procalcitonin in the absence of bacterial pneumonia
    Gautam, Samir
    Cohen, Avi J.
    Stahl, Yannick
    Valda Toro, Patricia
    Young, Grant M.
    Datta, Rupak
    Yan, Xiting
    Ristic, Nicholas T.
    Bermejo, Santos D.
    Sharma, Lokesh
    Restrepo, Marcos, I
    Dela Cruz, Charles S.
    THORAX, 2020, 75 (11) : 974 - 981
  • [23] The Oral Bacterial Communities of Children with Well-Controlled HIV Infection and without HIV Infection
    Goldberg, Brittany E.
    Mongodin, Emmanuel F.
    Jones, Cheron E.
    Chung, Michelle
    Fraser, Claire M.
    Tate, Anupama
    Zeichner, Steven L.
    PLOS ONE, 2015, 10 (07):
  • [24] Emergence of multi-drug resistant bacterial infection of lower respiratory tract among people living with HIV
    Maharjan, R.
    Bastola, A.
    Adhikari, N.
    Rijal, K. R.
    Ghimire, P.
    Shrestha, U. T.
    TROPICAL MEDICINE & INTERNATIONAL HEALTH, 2021, 26 : 41 - 41
  • [25] Bacterial pneumonia in HIV-infected patients (excluding mycobacterial infection)
    Godet, C.
    Beraud, G.
    Cadranel, J.
    REVUE DES MALADIES RESPIRATOIRES, 2012, 29 (08) : 1058 - 1066
  • [26] Incidence of hypertension in people with HIV infection: a longitudinal observational study
    Gelpi, Marco
    Karvig, Luanna Uchoa
    Knudsen, Andreas Dehlbaek
    Sorensen, Edith Wolder
    Benfield, Thomas
    Afzal, Shoaib
    Nielsen, Susanne Dam
    AIDS, 2023, 37 (11) : 1705 - 1709
  • [27] Acute Respiratory Infection Incidence and Outpatient Antibiotic Prescription Patterns in People With or Without Human Immunodeficiency Virus Infection: A Virtual Cohort Study
    Sweet, L.
    Daniels, C.
    Xu, X.
    Sunil, T.
    Topal, S.
    Chu, X.
    Noiman, A.
    Barsoumian, A.
    Ganesan, A.
    Agan, B. K.
    Okulicz, J. F.
    OPEN FORUM INFECTIOUS DISEASES, 2023, 10 (07):
  • [28] Trends in the Epidemiology of Pneumocystis Pneumonia in Immunocompromised Patients without HIV Infection
    Xue, Ting
    Kong, Xiaomei
    Ma, Liang
    JOURNAL OF FUNGI, 2023, 9 (08)
  • [29] Prognostic factors of Pneumocystis jirovecii pneumonia in patients without HIV infection
    Kim, Soo Jung
    Lee, Jinwoo
    Cho, Young-Jae
    Park, Young Sik
    Lee, Chang-Hoon
    Yoon, Ho
    Lee, Sang-Min
    Yim, Jae-Joon
    Lee, Jae Ho
    Yoo, Chul-Gyu
    Lee, Choon-Taek
    Kim, Young Whan
    Han, Sung Koo
    Kim, Hong Bin
    Park, Jong Sun
    JOURNAL OF INFECTION, 2014, 69 (01) : 88 - 95
  • [30] Comparison of Pneumocystis jiroveci pneumonia characteristics in patients with and without HIV infection
    Luisa Aznar, Maria
    Perez-Fernandez, Naiara
    Ruiz-Camps, Isabel
    Teresa Martin-Gomez, M.
    ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA, 2014, 32 (08): : 545 - 547